A placebo-controlled dose response study
โ
Dr. U. Ganzinger; H. Bachmayer; E. Liehl; J. J. Martindale; F. Hamilton; Dr. E.
๐
Article
๐
1988
๐
John Wiley and Sons
๐
English
โ 498 KB
A live cold-recombinant influenza B virus vaccine (RB77) was given intranasally in a placebo-controlled, double blind study to volunteers in dosages of 10(7.9) EID50/ml, 10(7.25) EID50/ml, 10(5.7) EID50/ml. The tolerability, safety, and immunogenicity of the vaccine were investigated. No revertant v